SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster

Published:2023-11 Issue:10415 Volume:402 Page:1827-1828
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wang Qian,Bowen Anthony,Ho Jerren,Zhang Richard M,Valdez Riccardo,Stoneman Emily,Gordon Aubree,Liu Lihong,Ho David D

Funder

National Institute of Allergy and Infectious Diseases

Columbia University

National Institutes of Health

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Antibody response to omicron BA.4–BA.5 bivalent booster;Wang;N Engl J Med,2023

2. Immunogenicity of BA.5 bivalent mRNA vaccine boosters;Collier;N Engl J Med,2023

3. SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster;Wang;Lancet Infect Dis,2023

4. Waning immunity against XBB.1·5 following bivalent mRNA boosters;Lasrado;bioRxiv,2023

5. Interim recommendations for use of bivalent mRNA COVID-19 vaccines for persons aged ≥6 months—United States, April 2023;Moulia;MMWR Morb Mortal Wkly Rep,2023

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative immunogenicity of monovalent and bivalent adenovirus vaccines carrying spikes of early and late SARS-CoV-2 variants;Emerging Microbes & Infections;2024-08-19

2. Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses;Human Vaccines & Immunotherapeutics;2024-08-16

3. Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster;Cell Reports Medicine;2024-08

4. Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives;Journal of the Formosan Medical Association;2024-08

5. Original Antigenic Sin on Antibody Response in SARS-CoV-2 Infection;Infectious Diseases & Immunity;2024-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3